CTNI-27. MULTI-CENTER, PHASE 2 STUDY EVALUATING THE PHARMACOKINETICS, SAFETY AND PRELIMINARY EFFICACY OF PAXALISIB IN NEWLY DIAGNOSED ADULT PATIENTS WITH UNMETHYLATED GLIOBLASTOMA (GBM)

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC9660971 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature